Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BBIO compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
BBIO
BridgeBio Pharma, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
BBIO
BridgeBio Pharma, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
BBIO
with
LLY
Uncorrelated: r 0.22 · 500D.
No shared co-movers.
BBIO, solid
LLY, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes
BBIO
BridgeBio Pharma, Inc.
Change
74.26
· pre 74.00
· delayed
Mkt cap
$14.5B
Revenue
$353M
Q3 FY26
Revenue
$502M
FY25
LLY
ELI Lilly & Co
Change
1,371.32
· pre 1,349.70
· delayed
Pre-market
Nov 6 '26
delayed
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Pre-market
Nov 6 '26
delayed
BBIO
BridgeBio Pharma, Inc.
vs
LLY
ELI Lilly & Co
74.26
pre 74.00
delayed
Price
1,371.32
pre 1,349.70
delayed
$14.5B
Mkt cap
$1.2T
Q3 FY26
$353M
Revenue
$24.4B
Q3 FY26
FY25
$502M
Revenue
$65.2B
FY25
Change
Change
BBIO
74.26
vs
LLY
1,371.32
Pre-market
Nov 6 '26
delayed